by John Anthony, The Truth Monster, ©2023

(Jan. 18, 2023) — So now there is evidence Fauci and his staff approved the bivalent boosters knowing they had a potential for harm, and did a worse job preventing infection than existing treatments.

This is not just another way for pharma and Fauci to get rich. As one astute observer mentions, if they really wanted to make a bundle, all pharma had to do was release a placebo, vaccinate billions, then wait for the relatively common COVID virus to pass.

Greg Piper at Just the News breaks it all down.

Less than a month after the CDC marked the two-year anniversary of the first administered COVID-19 vaccine by telling Americans to get a bivalent booster, two peer-reviewed German studies have found that mRNA vaccines — the vast majority of the U.S. market — induce worse antibodies compared to traditional adenovirus vaccines.

The first paper, published in Science Immunology Dec. 22, focused on mRNA boosters, while the second, published in Frontiers in Immunology Jan. 12, found the same association with the two-dose primary series.

The Frontiers paper has the added distinction of a Pfizer scientist serving as its editor and one of Anthony Fauci’s staffers at the National Institute of Allergy and Infectious Diseases as a peer reviewer, suggesting the mRNA vaccine maker and feds were aware of a potential antibody problem around the time Omicron-targeting boosters were authorized.

The findings call into question the government’s promotion of bivalent boosting even while regulators admit that newer COVID variants are evading vaccines.

New York City’s Department of Health told residents Friday the XBB.1.5 Omicron subvariant now comprises three-quarters of documented COVID infections in the city. 

It is “the most transmissible form of COVID-19 that we know of to date and may be more likely to infect people who have been vaccinated or already had COVID-19,” the department tweeted. It didn’t answer Just the News queries about the evidence for its claims about vaccination or prior infection.

The CDC said XBB.1.5 accounted for 43% of documented infections nationwide last week, with under 3% from BA.5, which is part of the bivalent cocktail. University of Tokyo virologists shared research Sunday that found XBB.1.5 exhibits “profound immune resistance” and “augmented ACE2 binding affinity,” and hence “increased transmissibility,” due to specific mutations.

While the World Health Organization deemed XBB variants “the most antibody-resistant variants to date” in a “rapid risk assessment” last week, it said XBB.1.5 specifically “does not carry any mutation known to be associated with potential change in severity.”


Read the rest here.

Leave a comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.